Srnovrsnik T, Pinter B, Horvat M, Tratnik J, Falnoga I, Mazej D
Metabolites. 2025; 15(2).
PMID: 39997704
PMC: 11857836.
DOI: 10.3390/metabo15020079.
Shi M, Li X, Xing L, Li Z, Zhou S, Wang Z
Pharmaceutics. 2025; 16(12.
PMID: 39771535
PMC: 11678845.
DOI: 10.3390/pharmaceutics16121556.
Zhu Y, Lin S, Zhang Y, Yu J, Fu J, Li Y
Sci Rep. 2024; 14(1):26215.
PMID: 39482365
PMC: 11528117.
DOI: 10.1038/s41598-024-77645-7.
Wen X, Wang L, Bai E
Front Endocrinol (Lausanne). 2024; 15:1370578.
PMID: 39109080
PMC: 11300195.
DOI: 10.3389/fendo.2024.1370578.
Cai J, Luo X, Wang Z, Chen Z, Huang D, Cao H
Heliyon. 2024; 10(9):e29879.
PMID: 38711644
PMC: 11070807.
DOI: 10.1016/j.heliyon.2024.e29879.
Placental mRNA Expression of Neurokinin B Is Increased in PCOS Pregnancies with Female Offspring.
Markantes G, Panagodimou E, Koika V, Mamali I, Kaponis A, Adonakis G
Biomedicines. 2024; 12(2).
PMID: 38397936
PMC: 10886712.
DOI: 10.3390/biomedicines12020334.
PCOS stratification for precision diagnostics and treatment.
Joshi A
Front Cell Dev Biol. 2024; 12:1358755.
PMID: 38389707
PMC: 10881805.
DOI: 10.3389/fcell.2024.1358755.
Possible Effect of Polycystic Ovary Syndrome (PCOS) on Cardiovascular Disease (CVD): An Update.
Profili N, Castelli R, Gidaro A, Manetti R, Maioli M, Petrillo M
J Clin Med. 2024; 13(3).
PMID: 38337390
PMC: 10856325.
DOI: 10.3390/jcm13030698.
Development of an acute ovine model of polycystic ovaries to assess the effect of ovarian denervation.
Duncan W, Nicol L, OHare R, Witherington J, Miranda J, Campbell B
Front Endocrinol (Lausanne). 2023; 14:1285269.
PMID: 37941906
PMC: 10628477.
DOI: 10.3389/fendo.2023.1285269.
Assessment of Type 2 Diabetes Risk in Young Women with Polycystic Ovary Syndrome.
Livadas S, Paparodis R, Anagnostis P, Gambineri A, Bjekic-Macut J, Petrovic T
Diagnostics (Basel). 2023; 13(12).
PMID: 37370962
PMC: 10297688.
DOI: 10.3390/diagnostics13122067.
Infertility and Social Issue Have the Most Significant Impact on Health-related Quality of Life among Polycystic Ovarian Syndrome Women in South India.
Hariprasath L, Selvakumar D, Dharani V, Durgalakshmi K, Abilash V, Gopenath T
J Hum Reprod Sci. 2023; 16(1):36-41.
PMID: 37305774
PMC: 10256948.
DOI: 10.4103/jhrs.jhrs_175_22.
Comparative Evaluation of Sildenafil Citrate and Estrogen as an Adjuvant Therapy for Treatment of Unexplained Infertility in Women.
Altyar A, Boshra M, Abou Warda A, Shawkey S, Abdallah Mohamed Salem S, Sarhan R
J Pers Med. 2023; 13(5).
PMID: 37241011
PMC: 10223516.
DOI: 10.3390/jpm13050842.
The Visceral Adiposity Index (VAI) and Lipid Accumulation Product (LAP) Are Predictors of Insulin Resistance and Hyperandrogenaemia in Obesity/Overweight Women with Polycystic Ovary Syndrome.
Wang H, Cao H, Cao J, Zhang L
Biomed Res Int. 2023; 2023:1508675.
PMID: 36814799
PMC: 9940946.
DOI: 10.1155/2023/1508675.
Binge Eating Disorder-The Point Prevalence among Polish Women with Polycystic Ovary Syndrome and Validity of Screening Tool for This Population.
Suchta K, Smolarczyk R, Czajkowski K, Rudnicka E, Kokoszka A
Int J Environ Res Public Health. 2023; 20(1).
PMID: 36612867
PMC: 9819692.
DOI: 10.3390/ijerph20010546.
Quercetin and polycystic ovary syndrome.
Ma C, Xiang Q, Song G, Wang X
Front Pharmacol. 2023; 13:1006678.
PMID: 36588716
PMC: 9800798.
DOI: 10.3389/fphar.2022.1006678.
Adiponectin to Leptin Ratio and its Association with Insulin Resistance in Women with Polycystic Ovarian Syndrome.
Mishra P, Mittal P, Rani A, Bharti R, Agarwal V, Suri J
Indian J Endocrinol Metab. 2022; 26(3):239-244.
PMID: 36248039
PMC: 9555382.
DOI: 10.4103/ijem.ijem_137_22.
Insulin Receptor Substrate 1 Gly972Arg (rs1801278) Polymorphism Is Associated with Obesity and Insulin Resistance in Kashmiri Women with Polycystic Ovary Syndrome.
Rasool S, Nabi M, Ashraf S, Amin S
Genes (Basel). 2022; 13(8).
PMID: 36011374
PMC: 9408134.
DOI: 10.3390/genes13081463.
Anxiety and Depression in Women with Polycystic Ovary Syndrome.
Dybciak P, Humeniuk E, Raczkiewicz D, Krakowiak J, Wdowiak A, Bojar I
Medicina (Kaunas). 2022; 58(7).
PMID: 35888661
PMC: 9319705.
DOI: 10.3390/medicina58070942.
The Lifestyle Modifications and Endometrial Proteome Changes of Women With Polycystic Ovary Syndrome and Obesity.
Abdulkhalikova D, Sustarsic A, Vrtacnik Bokal E, Jancar N, Jensterle M, Burnik Papler T
Front Endocrinol (Lausanne). 2022; 13:888460.
PMID: 35813634
PMC: 9258031.
DOI: 10.3389/fendo.2022.888460.
Rhamnocitrin Attenuates Ovarian Fibrosis in Rats with Letrozole-Induced Experimental Polycystic Ovary Syndrome.
Zhou Y, Lan H, Dong Z, Li W, Qian B, Zeng Z
Oxid Med Cell Longev. 2022; 2022:5558599.
PMID: 35663203
PMC: 9162838.
DOI: 10.1155/2022/5558599.